|Other Names||Zinc finger protein PLAGL1, Lost on transformation 1, LOT-1, Pleiomorphic adenoma-like protein 1, Tumor suppressor ZAC, PLAGL1, LOT1, ZAC|
|Target/Specificity||The synthetic peptide sequence is selected from aa 132-146 of HUMAN PLAGL1|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Shows weak transcriptional activatory activity. Transcriptional regulator of the type 1 receptor for pituitary adenylate cyclase-activating polypeptide.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Shows weak transcriptional activatory activity. Transcriptional regulator of the type 1 receptor for pituitary adenylate cyclase-activating polypeptide.
Abdollahi A.,et al.Oncogene 14:1973-1979(1997).
Kas K.,et al.J. Biol. Chem. 273:23026-23032(1998).
Varrault A.,et al.Proc. Natl. Acad. Sci. U.S.A. 95:8835-8840(1998).
Bilanges B.,et al.Oncogene 20:1246-1253(2001).
Varrault A.,et al.Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
If you have any additional inquiries please email technical services at email@example.com.